Similarly, G-CSF levels were increased in the GVHD group compared with DED group (273.53 ± 222.18 vs. 42.85 ± 104.12, p < 0.001), and no significant difference was noted between the GVHD and non-GVHD groups (366.13 ± 343.70, p = 0.395). Here, CSF3 is linked to graft versus host disease.